Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. by A. Corti et al.
Contribution by Polymorphonucleate Granulocytes to
Elevated Gamma-Glutamyltransferase in Cystic Fibrosis
Sputum
Alessandro Corti1*, Maria Franzini2,3, Silvana Cianchetti4, Gabriella Bergamini5,6, Evelina Lorenzini1,
Paola Melotti5, Aldo Paolicchi1,3, Pierluigi Paggiaro4, Alfonso Pompella1
1Dipartimento di Patologia Sperimentale, Universita` di Pisa, Scuola Medica, Pisa, Italy, 2 Scuola Superiore S. Anna, Pisa, Italy, 3 Fondazione Toscana G. Monasterio, CNR,
Regione Toscana, Pisa, Italy, 4Dipartimento Cardio Toracico e Vascolare, Universita` di Pisa, Pisa, Italy, 5Centro Fibrosi Cistica, Azienda Ospedaliera di Verona, Verona, Italy,
6Dipartimento di Patologia e Diagnostica, Universita` di Verona, Verona, Italy
Abstract
Background: Cystic fibrosis (CF) is an autosomal recessive disorder characterized by a chronic neutrophilic airways
inflammation, increasing levels of oxidative stress and reduced levels of antioxidants such as glutathione (GSH). Gamma-
glutamyltransferase (GGT), an enzyme induced by oxidative stress and involved in the catabolism of GSH and its derivatives,
is increased in the airways of CF patients with inflammation, but the possible implications of its increase have not yet been
investigated in detail.
Principal Findings: The present study was aimed to evaluate the origin and the biochemical characteristics of the GGT
detectable in CF sputum. We found GGT activity both in neutrophils and in the fluid, the latter significantly correlating with
myeloperoxidase expression. In neutrophils, GGT was associated with intracellular granules. In the fluid, gel-filtration
chromatography showed the presence of two distinct GGT fractions, the first corresponding to the human plasma b-GGT
fraction, the other to the free enzyme. The same fractions were also observed in the supernatant of ionomycin and fMLP-
activated neutrophils. Western blot analysis confirmed the presence of a single band of GGT immunoreactive peptide in the
CF sputum samples and in isolated neutrophils.
Conclusions: In conclusion, our data indicate that neutrophils are able to transport and release GGT, thus increasing GGT
activity in CF sputum. The prompt release of GGT may have consequences on all GGT substrates, including major
inflammatory mediators such as S-nitrosoglutathione and leukotrienes, and could participate in early modulation of
inflammatory response.
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Introduction
Cystic fibrosis (CF) is an autosomal recessive disorder due to
mutations in the cystic fibrosis trans-membrane conductance
regulator protein (CFTR) [1,2], a cyclic AMP-regulated anion
channel primarily involved in chloride and bicarbonate transport
but also permeable to other larger organic anions such as
glutathione (GSH) [3,4]. CFTR impairment has a wide impact
on the functions of several tissues but, in particular, it is associated
with alterations of biophysical properties of airway secretions [5]
leading to chronic airway infection and inflammation, the latter
mainly dominated by neutrophils [6,7]. Such conditions are
associated with increased levels of oxidative stress in the lung and
several studies have therefore focused on the antioxidant/oxidants
balance in CF, with particular interest on GSH and GSH-
associated enzymes [1,2]. GSH is one of the major water-soluble
antioxidants and its chemical properties make it able to play a role
also in mucolysis, regulation of inflammation, immune response
and cell viability [1]. Interestingly, GSH concentrations are
markedly reduced in CF airways and plasma [8], and several
factors (e.g. chronic inflammation, oxidative stress, impaired
CFTR-mediated GSH transport) may contribute to this effect.
Gamma-glutamyltransferase (GGT) is a membrane-bound
enzyme involved in the metabolism and recuperation of
extracellular glutathione by cells. GGT is also involved in S-
nitrosoglutathione and leukotrienes metabolisms [9,10] and
several studies documented its role in promoting pro-oxidant
reactions, thanks to the highly reactive GSH-derivative cysteinyl-
glycine [11]. Indeed, cysteinyl-glycine can be considered as a
marker of GGT activity and its ability in promoting protein S-
thiolation was also shown [12].
GGT expression can be induced by oxidative stress [13,14] and
inflammatory cytokines, such as TNF-alpha, IFN-alpha and –beta
(see [11] for a recent review). Interestingly, a significant increase in
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GGT activity was described in the bronchoalveolar lavage of
young children with pulmonary inflammation due to CF [15] and
such increase was interpreted as a response to inflammation-
related oxidative stress, likely providing bronchial cells with a
mechanism for an increased recovery of extracellular glutathione
[1,15]. Higher GGT activities were also detected in vitro in cultured
CF cell lines [4,16], suggesting that the GGT increase in CF lungs
may be directly related with CFTR defective function. Neverthe-
less other non-epithelial sources should be taken into account
when considering the GGT increase in CF lungs. In particular,
some studies demonstrated the expression of GGT in human
lymphoid cells and an increase of GGT activity was described in
the granulocytic cell lineage along with cell maturation [17],
during differentiation of lymphocytes [18] and monocytes/
macrophages [19]. In neutrophils GGT is localized in microsomal
and granular fractions and released upon neutrophils activation
with calcium-ionophore A23187 [9,17,20].
The aim of the present work was to assess the origin and the
biochemical characteristics of the GGT detectable in CF sputum
in comparison with the enzyme released by activated neutrophils,
in order to appraise the contribution of inflammation-derived
GGT to the increased activity described in CF lungs.
Materials and Methods
Chemicals
Unless otherwise indicated, all reagents were from Sigma
Chemical Co. (St. Louis, MO, USA).
Ethics Statement
The study was approved by Human Ethics Committee of
Azienda Ospedaliera of Verona and all subjects gave a written
informed consent. A written informed consent was also obtained
from the next of kin on the behalf of the minors participants
involved in the study.
Processing of cystic fibrosis sputum samples for GGT
assays
Spontaneously produced sputum samples (N. 7 specimens
obtained from 7 distinct CF patients) were collected from patients
affected by classical cystic fibrosis attending the Cystic Fibrosis
Center of Verona. The group included 4 males and 3 females with
age ranging from 15 to 36 years and different severity of lung
function impairment (forced expiratory volume in one second
(FEV1) ranging from 29% to 86% expected value). Samples from
bronchiectasis patients (2 males, 3 females; age from 61 to 78) were
used as neutrophils-dominated, chronic airways inflammation
control. For total GGT measurements, samples were diluted 8-
fold in 10 mM Tris-HCl pH 7.8, including Triton X-100 (1% v/v)
and sonicated. For soluble GGT measurements, sputum samples
were diluted with an equal volume of 0.1% w/v dithiothreitol
(Sputasol; Unipath, Basingstoke, UK), incubated in a shaking bath
at 37uC for 15 min, then gently mixed to further dissolve mucus
plugs. At the end of incubation, samples were filtered through a
53 mm nylon gauze to remove debris [21]. Filtered samples were
centrifuged at 4006g (7 min, RT), then at 10,0006g (10 min, 4uC).
Both soluble fraction (supernatant) and insoluble pellet (resuspended
in PBS) were collected. All samples were stored at 280uC.
Determination of low molecular weight thiols in cystic
fibrosis sputum
Determination of low molecular weight thiols was performed as
previously described [12] on whole sputum samples acidified with
10% trichloroacetic acid. Samples were reduced with tris(2-
carboxyethyl)phosphine (Molecular Probes), and derivatized with
the thiol-reagent 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate
(Fluka). Thiols concentration was determined by HPLC system.
Cytochemical staining for GGT activity
Cystic fibrosis sputum smears were fixed in a phosphate-
buffered acetone formaldehyde mixture (PBAF) and stained with
gamma-glutamyl-4-methoxy-2-naphtylamide and Fast Garnet
GBC as previously described [17]. Nuclei were counterstained
with Mayer’s hemalum solution.
Isolation and activation of neutrophils
Neutrophils were isolated from the blood of healthy donors as
described [22]. Fresh buffy coats were incubated with 1% Dextran
T500. Leukocyte-rich supernatants were recovered and contam-
inating erythrocytes lysed with distilled water; neutrophils were
separated by centrifugation on Histopaque-1077. Cell number and
viability were assessed by Turk’s staining and Trypan blue
exclusion. All manipulations were performed under sterile
conditions at 4uC. Neutrophils (56106 cells/ml) were incubated
in RPMI-1640 at 37uC and challenged with 0.5 mM ionomycin
(15 min) or 1 mM formyl-methionyl-leucyl-phenylalanine (fMLP,
120 min); cell viability was assessed by Trypan blue exclusion.
Finally samples were centrifuged at 3006g (5 min, 4uC) then at
10,0006g (10 min, 4uC) before GGT determinations.
Isolation of neutrophils granules on Percoll gradients
Neutrophils granules were separated as described [23]. Isolated
neutrophils (2–56107 cells/ml) were pressurized in a nitrogen
bomb and the samples were collected dropwise. Nuclei and intact
cells were separated by centrifugation and the supernatants were
stored on ice. A discontinuos Percoll gradient was prepared by
stratifying three Percoll solutions with densities of 1.120, 1.090 and
1.050 g/ml. Supernatants were applied on top of the gradients
and centrifuged at 37,0006g (30 min, 4uC). Four main bands were
thus identified corresponding to (from bottom): a-band (containing
azurophil granules), b1-band (specific granules), b2-band (gelati-
nase granules), and c-band (secretory vesicles and plasma
membranes). Cytosol was separated on top of upmost band. The
five fractions and fractions among them were harvested through a
Pasteur pipette and stored at 220uC.
Fractional GGT analysis by high-performance gel-
filtration chromatography
Determination of GGT fractions was performed as previously
described [24,25] by a FPLC system (AKTA-purified-10, GE-
Healthcare). Separation and quantification of GGT fractions was
performed by gel-filtration chromatography (Superose 6 10/300,
GE Healthcare) followed by post-column injection of the
fluorescent substrate gamma-glutamyl-7-amido-4-methylcou-
marin. Intensity of the fluorescence signal was expressed in
arbitrary fluorescence units (f.u.) and the area under chromato-
graphic peaks was proportional to GGT activity.
Fractional GGT analysis on activated neutrophils supernatants
and solubilised sputum samples were both performed after
centrifugation at 10,0006g (30 min, 4uC) followed or not by
100,0006g (120 min, 4uC) ultracentrifugation.
Cell lines and culture conditions
CFTR-mutated IB3-1 cells derived from bronchial epithelium
of a CF patient [26] were obtained from Dr. P. Zeitlin (Johns
Hopkins University, MD, USA). IB3-1 cells were routinely grown
Gamma-Glutamyltransferase in Cystic Fibrosis
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in LHC-8 medium (Gibco) supplemented with 5% (v/v) foetal
bovine serum (FBS). Human alveolar basal epithelial A549 cells
[27] were grown in DMEM supplemented with 10% (v/v) FBS
and 2 mM L-glutamine (L-Gln). Cell lines were cultured at 37uC
in a 5%/95% CO2/air atmosphere.
Western blot analysis
The extracellular and cytoplasmatic levels of neutrophilic
myeloperoxidase (MPO) were evaluated by western blot analysis
of the solubilised sputum supernatants and cells lysates, respec-
tively. The sputum cells were directly lysed in sample buffer
(40 mM Tris-HCl pH 6.8, 183 mM b-mercaptoethanol, 1% (w/v)
SDS, 5% (v/v) glycerol), heated at 95uC for 5 min and passed
through a 23 gauge needle to fragment DNA. All samples were
separated by 12% SDS-PAGE and gels were blotted onto
nitrocellulose membrane (Hybond ECL; Amersham, UK). Mem-
branes were stained with Ponceau S to verify loading and transfer
efficiency. Nonspecific binding on the membrane was blocked with
5% (w/v) bovine serum albumin (BSA) in TBS-T buffer (0.2%
Tween 20 in Tris-buffered saline pH 7.5) for 1 hour at room
temperature. Membranes were incubated with 1:1,000 dilution of
rabbit polyclonal antibody raised against human MPO (Enzo Life
Sciences Inc, NY, USA) or 1:2,000 mouse monoclonal anti-
GAPDH (Life Technologies, Grand Island NY, USA) in TBS-T
with 1% BSA, overnight, at 4uC. Blot was washed three times in
TBS-T and then incubated for 1 hour at room temperature with
donkey anti-rabbit IgG secondary antibody or sheep anti-mouse
IgG conjugated to horseradish peroxidase (Amersham, NJ, USA)
diluted 1:15,000 in TBS-T. Bound proteins were visualized using
the ECL detection system (Amersham).
For western blot determinations of GGT, isolated neutrophils
and epithelial cell monolayers – harvested in hypotonic lysis buffer
(10 mM Tris–HCl, pH 7.8) – or aliquots of CF sputum were used.
All samples were separated by 12% SDS-PAGE and gels were
blotted onto nitrocellulose membranes. Nonspecific binding on the
membrane was blocked with 5% (w/v) non-fat milk/16 PBS-
0.01% Tween 20 for 30 min at room temperature. Blots were
incubated overnight, 4uC, with rabbit anti-GGT IgG (1:1000 in
2.5% (w/v) non-fat milk/16 PBS-0.01% Tween 20) directed
against the C-terminal 20 amino acids of human GGT heavy
chain and prepared as described [28]. Visualization of protein
bands was obtained using a horseradish peroxidase-conjugated
anti-rabbit IgG antibody (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) diluted 1:5,000 in 2.5% (w/v) non-fat milk/16 PBS-
0.01% Tween 20 (1 hour, room temperature), and the ECL
detection system (Roche, Basel, Switzerland).
Bands were quantified by densitometric analysis with a Bio-Rad
ChemiDoc apparatus equipped with the QuantityOne software.
Other determinations
GGT activity was determined according to Huseby and
Stro¨mme [29]. Protein content was determined by the method
of Bradford using the Bio-Rad protein assay reagent. Statistical
analysis of data was performed by linear regression analyses,
Student’s t-test and one-way ANOVA with Newman–Keuls test
for multiple comparisons.
Results
Characterization of GGT activity in whole CF sputum
The analysis of the whole CF sputum homogenates revealed the
presence of a mean GGT activity of 17.264.1 mU/mg of protein.
The presence of a catalytically active GGT in CF sputum was also
confirmed by the significant correlation between GGT activity and
both free cysteinyl-glycine (R2 = 0.811, p,0.01; Fig. 1A) and
protein bound cysteinyl-glycine (R2 = 0.917, p,0.001; Fig. 1B),
the latter being about five times higher than the free compound.
Interestingly, a significant (R2= 0.717, p,0.02), inverse correla-
tion was found between sputum GGT and FEV1 values of
enrolled patients (Fig. 2).
As expected, sputum smears revealed the presence of bacteria,
epithelial cells and a rich neutrophilic infiltrate, the latter
expressing significant levels of GGT activity (Fig. 3). No
correlation was found between GGT activity and microbiological
parameters (type of microorganism, early or chronic infection; see
Table 1).
Characterization of cell-free GGT activity in CF sputum
Gel-filtration chromatography of solubilised, cell-free sputum
samples revealed the presence two peaks of GGT activity eluting
respectively at 12.5 ml (‘‘b-GGT’’, MW.2000 kDa) and at
23.1 ml (‘‘f-GGT’’, 66 kDa) (Table 2). The same two peaks were
also found in bronchiectasis sputum samples used as control (data
not shown). The ratio between the two fractions varied
considerably among the samples analyzed, b-GGT being anyway
the prevalent fraction (Table 2). Gel-filtration chromatography of
ultracentrifuged solubilised sputum showed that b-GGT fraction
was mainly (90%) recovered in the pellet (Fig. 4A–B), while f-
GGT was almost totally found in the supernatant (Fig. 4A).
Interestingly, when MPO expression in cellular fraction of
Figure 1. Relationship between GGT activity and cysteinyl-
glycine (CysGly) levels in whole sputum. Data were obtained from
seven different samples of CF sputum. (A) Free and (B) protein bound
CysGly. A) R2 = 0,811, p,0.01; B) R2 = 0,917, p,0.001.
doi:10.1371/journal.pone.0034772.g001
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solubilised sputum were analyzed by SDS-PAGE, a significant
correlation (R2 = 0.683; p = 0.02) was found with total GGT
activity in the supernatants (Fig. 5). A significant correlation
(R2= 0.594; p = 0.04) was also found between MPO levels and
GGT activities revealed in solubilised sputum supernatants (data
not shown).
Characterization of GGT activity in resting and activated
neutrophils
When a subcellular fractionation of neutrophils on a Percoll
density gradient was performed, the presence of GGT activity was
detected in the c-band, containing secretory vesicles and plasma
membranes, and in the b1-band, containing the specific granules
(Fig. 6). Very low or no detectable GGT activity was found in a-
band and b2-band, corresponding to azurophil and gelatinase
granules, respectively.
Neutrophils were then exposed to activating substances
promoting granules release, and GGT activity was measured in
the incubation media. A time-dependent release of GGT was
observed in basal conditions (Fig. 7A), possibly as the result of a
weak activation during incubations [17,22]. Noteworthy, this
effect was significantly increased when neutrophils were activated
with the calcium ionophore ionomycin (Fig. 7B) or with the
formyl peptide fMLP (Fig. 7C).
Characterization of GGT released by activated
neutrophils
In order to better characterize the GGT released by activated
neutrophils, incubation media were centrifuged at 10,0006g, then
at 100,0006g. The 10,0006g supernatants of both ionomycin
(Fig. 8A) and fMLP (data not shown) activated neutrophils
displayed the presence of one major peak of activity, correspond-
ing to b-GGT observed in CF sputum, while only traces of f-GGT
were detectable. On the contrary, the corresponding pellet showed
no GGT activity (data not shown). When 100,0006g supernatants
and pellets were analyzed, b-GGT was found in both fractions
with a ratio of peak areas (corrected for the volumes) of 1:1
(Fig. 8B–C). Again, only minor f-GGT peaks were found in the
supernatants, while no f-GGT was detectable in the pellet
(Fig. 8B–C).
Comparison of sputum GGT with neutrophilic and
epithelial GGT
The possible origin of CF sputum GGT was investigated by
means of SDS-PAGE analysis with an antibody directed against
GGT heavy chain. Different whole sputum samples presented with
a single band, corresponding to the MW of GGT heavy chain
(75 kDa; Fig. 9A). A band with the same MW was observed in
healthy donors neutrophils homogenates (Fig. 9B), in soluble/
insoluble fractions of CF sputum (Fig. 9C) and in bronchiectasis
sputum samples (data not shown). Conversely, a different MW was
Figure 2. Relationship between sputum GGT activity and FEV1
values of CF patients. R2 = 0,717, p,0.02.
doi:10.1371/journal.pone.0034772.g002
Figure 3. Cytochemical staining for GGT enzyme activity in
sputum samples. (A) Neutrophils with different levels of GGT activity
in sputum films of patients with cystic fibrosis. (B) GGT-negative
epithelial cell surrounded by GGT-positive neutrophils is also shown.
Magnification 1006.
doi:10.1371/journal.pone.0034772.g003
Table 1. Microbiological characterization of CF sputum
samples.
Pt# Pseudomonas aeruginosa Staphylococcus aureus
1 No Yes, chronic
2 Yes, chronic Yes, chronic
3 No No
4 Yes, chronic Yes, chronic
5 Yes, chronic No
6 Yes, chronic No
7 Yes, chronic No
doi:10.1371/journal.pone.0034772.t001
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determined for GGT heavy chain in homogenates of different
epithelial and endothelial cell lines used for comparison: CF
bronchial epithelium IB3-1 cell line (Fig. 9B), human carcinoma
epithelial cell line A549 (Fig. 9C) and human endothelial cell line
HUVEC (data not shown), the latter employed as a model for the
highly represented endothelial cells in the lung.
Discussion
GGT plays an important role in the metabolism of GSH, S-
nitrosoglutathione [10] and leukotrienes [9], i.e. compounds
playing a central role as inflammatory mediators, and changes
occurring in the compartmentation of this enzyme activity can
therefore represent a critical process during the immune response.
The results obtained in this study suggest that GGT activity
present in CF sputum can originate – at least in part – from
polymorphonuclear granulocytes, as a result of their accumulation
and activation in CF airways. Increasing GGT levels in sputum
were correlated with both free and protein-bound levels of
cysteinyl-glycine (Fig. 1A–B), i.e. the highly reactive GSH
catabolite produced by GGT in the extracellular compartment.
The finding is in support of a direct role of GGT activity in
modulating both low molecular weight thiols balance (Fig. 1A)
and proteins thiols redox status (Fig. 1B) in CF lung. Previous
studies have shown that GGT can produce the cysteinyl-
glycylation of proteins, thus altering the levels of protein-bound
GSH and the overall protein S-thiolation status [12]. In the case of
Figure 4. High-performance gel filtration chromatography of
soluble fraction of CF sputum. Supernatants obtained from sputum
solubilisation and centrifugation at 10,0006g were ultracentrifuged
again at 100,0006g before analysis. A) 100,0006g supernatant; B)
100,0006g pellet. Data represent one representative separation out of
three and are expressed as arbitrary units (a.u.) of fluorescence.
doi:10.1371/journal.pone.0034772.g004
Figure 5. Relationship between GGT activity and MPO levels in
CF sputum samples. MPO levels were detected by western blot
analysis in samples of solubilised sputum pellets and correlated with
GGT activity of solubilised sputum supernatants. A) Lane 1–7, CF
samples; lane 8, control (neutrophils). B) Data reported are expressed as
a ratio of MPO against GADPH band densities, while GGT values are
normalized on protein content. R2 = 0.683; p = 0.02.
doi:10.1371/journal.pone.0034772.g005
Table 2. Total and fractional GGT activity in CF sputum.
Pt# Total GGT b-GGT f-GGT
1 13.1 5.2 4.7
2 19.6 9.8 5.2
3 21.6 14.1 2.1
4 28.1 15.8 12.2
5 48.2 29.3 18.9
6 84.1 46.8 37.3
7 90.2 50.9 30.4
CF sputum samples were solubilised, centrifuged at 10,0006g and the
supernatants analyzed by high-performance gel filtration chromatography. The
table reports the whole GGT activity of each solubilised sputum and the
activities corresponding to the two different GGT fractions identified by gel
filtration chromatography. Data were are expressed as U/L.
doi:10.1371/journal.pone.0034772.t002
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sputum, such effects could play a role in modulating the function/
solubility of airways proteins, such as thiols rich lung fluid mucins
[30].
Notably, we found a significant, inverse correlation between
sputum GGT activities and FEV1 values of corresponding patients
(Fig. 2). Nevertheless, no correlation was found between GGT
activity and parameters of microbial infection (see Table 1). The
number of samples studied is quite small and future studies –
enrolling a larger number of patients – will probably help to clarify
these specific points. Anyway, functional data seems to associate
the worsening of respiratory function with an increase of airways
GGT, thus prompting the question of the source of sputum GGT
(parenchimal or inflammatory).
In this respect, cytochemical staining for GGT activity
confirmed the presence of rich GGT-positive neutrophilic
infiltrates in all sputum samples. Neutrophils displayed different
levels of the enzyme (Fig. 3), possibly ensuing from differences in
GGT expression or activation. When solubilised cell-free samples
were analyzed by gel-filtration chromatography (Table 2), two
peaks of GGT activity were apparent displaying the same
molecular weights of two of the four GGT fractions found in
human plasma, b-GGT (MW.2000 kDa) and f-GGT (66 kDa)
[24], the former possibly representing a high molecular weight
protein aggregate and the latter corresponding to the free enzyme.
The same two peaks were also observed in solubilised, cell-free
samples of bronchiectasis patients sputum, used as a control for a
neutrophils-dominated, chronic airway inflammation process (data
not shown), thus suggesting an inflammatory origin of the
observed findings, rather than a specificity for cystic fibrosis.
According with this interpretation, we found a significant
correlation (R2 = 0.683; p= 0.02) between MPO expression in
cellular fraction of solubilised sputum and total GGT activity in
the supernatants (Fig. 5). MPO is a major constituent of
neutrophil cytoplasmic granules and its activity is proposed to be
a direct measure of neutrophil presence and an indirect indicator
of lung injury [31]. In this perspective, our results only suggest a
direct relationship between neutrophilic infiltrate and soluble
GGT fractions in sputum. With the aim to ascertain whether
neutrophils might be the source of that GGT, additional
experiments were performed with isolated neutrophils.
In agreement with early reports [9,20], our data confirmed the
presence of GGT in neutrophilic granules. In particular, GGT
activity was found in the subcellular fraction corresponding to
secretory vesicles and plasma membranes (c-fraction), as well as in
specific granules (Fig. 6). Actually, the similar density of plasma
Figure 6. GGT activity in neutrophils fractions obtained on
Percoll gradients. A high GGT activity was found in fractions c, b1 and
in the fractions between b2 and b1 (b2b1). Data reported were obtained
from neutrophils isolated from three different healthy donors.
Cy = cytosol; c= secretory vesicles and plasma membranes; b2 = gelati-
nase granules; b1 = specific granules; a= azurophilic granules; cb2, b2b1
and b1a are the fractions recovered among the main bands.
doi:10.1371/journal.pone.0034772.g006
Figure 7. GGT release by neutrophils. Neutrophils isolated from
fresh buffy coats were incubated in (A) RPMI-1640 alone, (B) in the
presence of ionomycin (0.5 mM; 15 min) or (C) fMLP (1 mM; 120 min).
GGT activity was measured in the 10,0006g centrifuged supernatants.
Results are means 6 SD of three separate determinations. Data were
analyzed by Student’s t test; (*) p,0.0001.
doi:10.1371/journal.pone.0034772.g007
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membranes and secretory vesicles precludes the complete
separation of these two components of c-fraction, and further
studies are needed to fully elucidate this specific point. On the
other hand, it was shown that secretory vesicles are almost
completely mobilized from neutrophils challenged with fMLP
[22], and that specific granules are mobilized by calcium
ionophore A23187 [20]. In our experiments, stimulation of
isolated neutrophils with fMLP produced a time-dependent release
of GGT activity (Fig. 7C), and the same was observed after
treatment with calcium ionophore ionomycin (Fig. 7B), suggest-
ing that the enzyme may indeed be associated with both secretory
vesicles and specific granules of neutrophils. Gel-filtration
chromatography of such activated neutrophils supernatants
revealed the presence of one major GGT fraction, i.e. b-GGT
(Fig. 8), corresponding to the same high molecular weight fraction
found in cell-free sputum samples (Table 2).
Based on this evidence, the possible neutrophilic origin of the
GGT fractions detected in cell-free sputum samples was further
investigated. When neutrophils or their supernatants were
compared with whole or solubilised CF sputum by SDS-PAGE,
GGT heavy chain presented with the same MW in all sample
analyzed, and this MW was different from GGT of epithelial (CF
bronchial epithelial cells IB3-1 and human alveolar A549 cell line;
Fig. 9) or endothelial origin (human endothelial cell line HUVEC;
used for comparison. Again, similar results
were also obtained from bronchiectasis sputum samples used as
control (data not shown). These findings are of particular interest,
for post translational glycosylation of GGT protein – and thus its
MW – is tissue specific [32], which allows a first, rough assessment
of GGT proteins expressed in different tissues. An amphipathic
GGT is physiologically secreted by alveolar epithelial type 2 cells
in association with lung surfactant [33], and inflammation-related
oxidative stress and cytokines can both induce GGT expression
and release by lung epithelial cells [34]. Our results actually
suggest that cell-free GGT in CF sputum can have a neutrophilic
rather than epithelial origin, even if it can not be excluded that
other GGT expressing inflammatory cells – such as macrophages
[17,35] – might also contribute to the phenomenon. Nevertheless,
the rich neutrophilic infiltrate, the significant correlation between
GGT activity and MPO expression and the ability of activated
neutrophils to release soluble GGT – with biochemical charac-
teristics similar to sputum GGT – are all in support of a
neutrophilic origin of GGT. This effect may be of particular
relevance – even though not specifically related – in cystic fibrosis,
where eosinophils as well as neutrophils have been suggested to
have an increased propensity to release their granule proteins
(ECP and MPO), due to still unknown priming mechanisms (e.g.
cytokines stimulation or upregulation of CR3-receptors) [36].
Figure 8. High-performance gel filtration chromatography of
ionomycin activated neutrophils supernatants. Samples were
centrifuged at 10,0006g or 100,0006g before analysis. (A) 10,0006g
supernatant; (B) 100,0006g supernatant; (C) 100,0006g pellet.
doi:10.1371/journal.pone.0034772.g008
Figure 9. Western blot analysis of GGT heavy chain in different
biological samples. (A) Lane 1–4, CF sputum; (B) lane 1, CF sputum;
lane 2–3, neutrophils; lane 4, IB3-1 cells; (C) lane 1, soluble fraction of CF
sputum; lane 2, insoluble fraction of CF sputum; lane 3, neutrophils;
lane 4, A549 cells.
doi:10.1371/journal.pone.0034772.g009
Gamma-Glutamyltransferase in Cystic Fibrosis
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34772
data not shown) 
As regards GGT fractions found in both activated neutrophils
supernatants and cell-free sputum samples, most of b-GGT was
recovered in ultracentrifugation pellets (Figs. 4, 8). The fact
that variable amounts of b-GGT were detected in supernatants
suggest a heterogeneous composition of such fraction, possibly
due to different origin/composition (e.g. secretory vesicles vs.
specific granules) or subsequent modification in the inflamma-
tory exudate (sputum). Previous studies showed that several cell
types can shed small vesicles, and two main vesicle-discharge
processes were identified leading to the release of distinct vesicle
types: i) exocytosis of multivesicular bodies, with the ensuing
release of exosomes, and ii) direct budding from plasma
membrane of ectosomes, also termed microparticles [37]. Mixed
vesicle populations were shown to be released upon activation by
different cell types, and the presence of released vesicles has been
detected in different body fluids such as urine, bronchoalveolar
lavage fluid, saliva and blood [37]. Ectosomes were shown to be
released by neutrophils [22,38] and their involvement in
different functions in the immune response was proposed [37].
This could indeed be also the case of neutrophilic GGT that –
similarly to transmembrane receptor CR1 [22] – is comprised in
complexes released upon cell activation with ionomycin or fMLP
(Fig. 7). In this way GGT activity could be increased in the
exudate more rapidly than in the case of its induction in
parenchymal cells, which could help to early modulate
inflammatory response through GGT substrates metabolism
(Fig. 10).
The low mol. weight fraction f-GGT was recovered only from
ultracentrifugation supernatants (Figs. 4, 8). It can be envisaged
that f-GGT might derive from the proteolytic cleavage of larger
aggregate b-GGT by proteases released during immune response.
In agreement with this interpretation, f-GGT was mainly found in
CF sputum (Fig. 4), while only traces were detectable in short-
term activated neutrophils supernatants (Fig. 8).
In conclusion, our data indicate that neutrophilic infiltrates
can explain the increase of GGT activity in neutrophils-
dominated airway inflammation processes, such those commonly
observed in CF lungs. GGT is promptly released upon
neutrophil activation, and this may have rapid consequences
on all GGT substrates, including major inflammatory mediators.
In this perspective, GGT increase in tissues should be interpreted
not only as a consequence of inflammation related oxidative
stress, but also as one of the effects of immune response.
Depending on what effects the increase in this enzyme activity
might produce on selected mediators, GGT could conceivably
represent an interesting pharmacological target in order to
modulate the inflammatory process. Further studies are however
needed to fully elucidate the mechanisms of GGT release, the
composition of GGT-containing particles and their actual role(s)
in the inflammatory process.
Figure 10. Neutrophils activation as a possible source of GGT in the airways during inflammation. GSNO, S-nitrosoglutathione.
doi:10.1371/journal.pone.0034772.g010
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